Invesaro

Stocks ALGT Financial statements

Financial statements

Allegiant Travel CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Allegiant Travel CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Revenue1,3791,5111,6671,8419901,7082,3022,5102,5132,607
Selling and marketing34.656.773.578.943.572.710111510699.4
Operating expenses1,0061,2811,4241,4771,2711,4452,2102,2892,7532,569
Operating income373231243364-28126391.6221-24037.2
Interest expense28.842.256.176.861.768.5116153156150
Interest income3.015.819.2312.55.511.8116.546.64441.7
Other non-operating income-24.6-31.6-44.162.7-80.1-66.5-86.7-61.9-68.5-92
Pre-tax income348199199301-3611974.95159-308-54.9
Income tax1270.8637.569.1-17744.82.4641.5-68.2-10.2
Net income to minority interests00
Net income221198162232-1841522.49118-240-44.7
EBITDA478352373520-10544428944418.3286
EPS, basic13.3112.1410.0214.27-11.538.690.146.32-13.49-2.48
EPS, diluted13.2912.1310.0014.26-11.538.680.146.29-13.49-2.48
Shares, basic (weighted)16.516.115.9161617.21817.917.918.1
Shares, diluted (weighted)16.516.116161617.2181817.918.1
Dividend per share2.402.802.802.800.700.000.001.201.200.00

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Cash and equivalents64.759.481.5122153363230143286173
Short-term investments314336532819725671495633
Receivables40.771.13625.519262.710770.790.457.1
Other current assets2.695.320.221.0124.628.116263.167.652.4
Total current assets4225414955629441,3381,2741,001992968
Property, plant and equipment1,0951,5121,8472,2372,0502,2602,8113,4303,0702,948
Lease right-of-use assets022.111613011210181.263.4
Long-term investments12578.651.515.502.2363.35651.732.8
Other non-current assets1216.636.844.521.611493.998.761.549.5
Total assets1,6722,1802,4993,0113,2593,9914,5114,8574,4304,209
Accounts payable1620.127.527.734.243.658.354.562.164.5
Accrued liabilities96.7105122159116163226292181186
Deferred revenue250308307379353371363
Short-term debt86.2215152173217130153440455118
Total current liabilities3935445146136896638701,2001,2771,018
Long-term debt7229501,1191,2491,4421,6121,9441,8201,6121,682
Lease liabilities21.31021159582.462.454.2
Other non-current liabilities7.6713.410.912.324.430.811.79.4534.159.2
Total liabilities1,1981,6271,8082,1272,5602,7683,2913,5283,3403,157
Total debt8081,1651,2721,4221,6591,7662,1202,2822,08416.6
Paid-in capital238254271290330692709741761772
Retained earnings7539081,0251,2111,0161,1671,1701,2651,003959
Treasury stock-518-606-605-618-646-638-660-682-678-683
Other comprehensive income-0.23-2.84-0.660.1-0.032.061.263.993.954.64
Shareholders' equity4745536908846991,2241,2211,3291,0891,053
Total equity4745486908846991,2241,2211,3291,0891,053
Total liabilities and equity1,6722,1802,4993,0113,2593,9914,5114,8574,4304,209
Shares outstanding16.616.116.216.316.418.1

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2021FY2023FY2024FY2025
Net income221198162232-1841522.49118-240-44.7
Depreciation and amortization105122129156176181198223258249
Stock-based compensation9.3913.915.118.219.316.115.229.722.610.9
Deferred income tax30.642.738.268.569.343.82.1838.2-69-10.2
Change in receivables-18.2-30.635.610.54.39-14.7-33.929.44.3612.2
Change in payables9.214.88.63-2.17.0210.414.8-5.038.74
Cash from operations348391357442235538303423338390
Capital expenditures-200-580-335-507-281-244-435-528-300-315
Purchases of investments-687-1,249-1,267-891-567-949
Cash from investing-402-619-269-476-366-593-491-7225.58-220
Debt issued321498211875428282864643387639
Debt repaid-154-139-232-706-218-301-702-481-586-906
Stock issued0.611.60033500
Share buybacks-66.4-90.5-3.65-18.6-33.80-29.9-30.1-6.03-13.6
Dividends paid-67.5-45.7-45.2-45.6-11.400-22.1-21.90
Cash from financing32.6222-62.475.116528533.1213-201-281
Net change in cash-22.4-5.2625.340.933.5230-155-85.9143-112
Free cash flow148-19021.8-64.6-46.5295-132-10538.375.1
Interest paid26.53652.365.24843.582.9112107122
Income taxes paid111-18-41.62.1695.2129-0.311.018.74-15.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $79.09 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin4.9%Operating income / revenue.
EBITDA margin13.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.8%Pre-tax income / revenue.
Net margin0.9%Net income / revenue.
FCF margin3.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin14.5%Cash from operations / revenue.
Effective tax rate50.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)1.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)0.4%Net income / average total assets.
Return on invested capital (ROIC)2.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue11.0%Capital expenditures / revenue.
D&A / revenue8.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y3.7%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y4.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y21.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y-26.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y1,467.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-0.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y15.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y8.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y10.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y96.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y-100.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-3.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-4.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y8.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-5.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-2.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.83xCurrent assets / current liabilities.
Quick ratio0.71x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.65x(Cash + short-term investments) / current liabilities.
Debt / equity1.56xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets43.1%Total debt / total assets.
Liabilities / assets72.4%Total liabilities / total assets.
Net debt$1.73BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA4.45xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$274.2MCurrent assets - current liabilities.
Tangible book value$1.78BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.45xRevenue / average total assets.
Fixed asset turnover0.68xRevenue / average property, plant and equipment.
Receivables turnover27.0xRevenue / average receivables.
Days sales outstanding14 days365 x average receivables / revenue.
FCF conversion396.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow75.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.14Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$126.64Revenue / diluted weighted shares.
FCF per share$4.51Free cash flow / diluted weighted shares.
Operating cash flow per share$18.39Cash from operations / diluted weighted shares.
Book value per share$77.78Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$77.78Tangible book value / shares outstanding.
Cash per share$46.10(Cash + short-term investments) / shares outstanding.
Buybacks / FCF2.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.16BShare price x shares outstanding.
Enterprise value$3.89BMarket cap + total debt - cash - short-term investments.
P/E83.2xMarket cap / net income. Only when net income is positive.
P/S0.75xMarket cap / revenue.
P/B1.22xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.22xMarket cap / tangible book value, when positive.
P/FCF21.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF5.14xMarket cap / cash from operations, when positive.
EV/Sales1.34xEnterprise value / revenue.
EV/EBIT27.4xEnterprise value / operating income, when both are positive.
EV/EBITDA10.0xEnterprise value / EBITDA, when both are positive.
EV/FCF37.7xEnterprise value / free cash flow, when both are positive.
FCF yield4.8%Free cash flow / market cap.
Earnings yield1.2%Net income / market cap (the inverse of P/E).
Shareholder yield0.1%(Dividends paid + share buybacks) / market cap.
What was Allegiant Travel CO's revenue in fiscal 2025?

Allegiant Travel CO reported revenue of $2.61B for fiscal 2025, 3.7% higher than the year before.

Was Allegiant Travel CO profitable in fiscal 2025?

No. It reported a net loss of $44.7M.

How much free cash flow did Allegiant Travel CO generate in fiscal 2025?

Cash from operations of $389.8M minus capital expenditures of $314.7M left free cash flow of $75.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Allegiant Travel CO